0000950170-24-008808.txt : 20240130 0000950170-24-008808.hdr.sgml : 20240130 20240130160313 ACCESSION NUMBER: 0000950170-24-008808 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240126 FILED AS OF DATE: 20240130 DATE AS OF CHANGE: 20240130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Angulo Gonzalez David CENTRAL INDEX KEY: 0001644071 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36365 FILM NUMBER: 24578129 MAIL ADDRESS: STREET 1: C/O SCYNEXIS, INC. STREET 2: 3501 C TRICENTER BOULEVARD CITY: DURHAM STATE: NC ZIP: 27713 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SCYNEXIS INC CENTRAL INDEX KEY: 0001178253 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 562181648 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 EVERTRUST PLAZA STREET 2: 13TH FLOOR CITY: JERSEY CITY STATE: NJ ZIP: 07302-6548 BUSINESS PHONE: 201-884-5485 MAIL ADDRESS: STREET 1: 1 EVERTRUST PLAZA STREET 2: 13TH FLOOR CITY: JERSEY CITY STATE: NJ ZIP: 07302-6548 4 1 ownership.xml 4 X0508 4 2024-01-26 0001178253 SCYNEXIS INC SCYX 0001644071 Angulo Gonzalez David 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302 true true false false Chief Executive Officer false Common Stock 2024-01-26 4 A false 290590 0.00 A 479871 D Employee Stock Option (Right to Buy) 1.86 2024-01-26 4 A false 431030 0 A 2034-01-25 Common Stock 431030 431030 D Represents restricted stock units that vest one third per year over three years as measured from February 15, 2024. Includes 4,100 shares of common stock acquired under the 2014 Employee Stock Purchase Plan in March 2023 (100 shares) and September 2023 (4,000 shares). 1/48th of the shares subject to the option vest monthly for 48 months as measured from February 15, 2024. /s/ Robert F. Joyce Jr., by Power of Attorney 2024-01-30